PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
17-Sep-2024 Formycon will present clinical data on its ustekinumab biosimilar candidate FYB202 at the EADV Congress in Amsterdam and the UEG Week in Vienna Formycon AG
16-Sep-2024 Gerresheimer: EcoVadis Gold with further improved score Gerresheimer AG
16-Sep-2024 Curatis: Deutlich gesteigerter Umsatz im Kerngeschäft und Projekte in Entwicklungs-Pipeline auf Kurs Curatis Holding AG
15-Sep-2024 Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights Marinomed Biotech AG
13-Sep-2024 Nordic Biotech Company Raises Capital for New International Obesity Study Pila Pharma
13-Sep-2024 Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients Moberg Pharma AB
13-Sep-2024 Almirall raises awareness of the mental burden of skin diseases launching the campaign “The True Colours of Atopic Dermatitis” Almirall
13-Sep-2024 CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress CureVac
12-Sep-2024 Teilnahme an der Investora am 19. September 2024 und frühere Publikation des Halbjahresreports am 16. September Curatis Holding AG
12-Sep-2024 Medacta Introduces a Simplified Approach for the M-ARS ACL Technique at the AGA Congress 2024, Mimicking the Native Ligament Footprint with an Optimized Surgical Flow Medacta Group SA
12-Sep-2024 RYBREVANT®▼ (amivantamab) plus lazertinib shows favourable overall survival trend in EGFR-mutated advanced non-small cell lung cancer (NSCLC) compared to osimertinib Johnson & Johnson
12-Sep-2024 Change in the Chief Financial Officer at Biotest AG Biotest AG
12-Sep-2024 Pentixapharm Holding AG, a Subsidiary of Eckert & Ziegler SE, Plans IPO on the Prime Standard of the Frankfurt Stock Exchange Pentixapharm Holding AG
12-Sep-2024 CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program CureVac
12-Sep-2024 PharmaSGP continues dynamic growth path in the first half of 2024 PharmaSGP Holding SE
12-Sep-2024 PharmaSGP Holding SE resolves on public share repurchase offer to buy back own shares for up to 594,405 shares PharmaSGP Holding SE
11-Sep-2024 PRODUCTLIFE GROUP ACQUIRES OUTCOMES’10, EXPANDING EUROPEAN MARKET ACCESS CAPABILITIES PRODUCTLIFE GROUP
11-Sep-2024 Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification Marinomed Biotech AG
10-Sep-2024 ContinuumCloud and DrFirst Partner to Enhance Prescribing Workflows and Patient Safety DrFirst
10-Sep-2024 Book a meeting with Gaelic Laboratories at CPHI Milan! Gaelic Laboratories